Status:
SUSPENDED
Cognitive Behavioral Sleep Intervention for Prevention of Type 2 Diabetes
Lead Sponsor:
The University of Hong Kong
Conditions:
PreDiabetes
Insomnia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The proposed study aims to evaluate if improving sleep could enhance the intensive lifestyle intervention for improving weight loss and glycemic control in prediabetic individuals who have insomnia wi...
Eligibility Criteria
Inclusion
- (a) Hong Kong residents,
- (b) BMI \> 23kg/m2,
- (c) aged 18 to 65 year-old,
- (d) have prediabetes, defined by a plasma fasting glucose concentration of 5.6 to 6.9 mmol/L, impaired glucose tolerance (2hglucose 7.8-11.0 on OGTT), or HbA1c 5.7-6.4%,
- (e) have average habitual sleep duration \< 6.5 hours, confirmed by actigraphy measure of sleep for 2 weeks or have insomnia, confirmed in a clinical sleep interview and actigraph-measure of greater than 30 minutes of sleep onset latency or nighttime awakening for 3 nights or more per week
Exclusion
- (a) have unmanaged sleep apnea or other sleep disorders,
- (b) have any current severe mental illnesses,
- (c) have any medical conditions or medication use that could undermine the efficacy of the sleep intervention,
- (d) have shift work schedules,
- (e) have any environmental constraints on the feasibility of implementing a sleep schedule of at least 7.5 hours
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04457440
Start Date
July 1 2020
End Date
December 30 2021
Last Update
October 25 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hpspital
Hong Kong, Hong Kong
2
The University of Hong Kong
Hong Kong, Hong Kong